FDA Commercial Speech Regs Constitutionality Debate Opened By Agency
This article was originally published in The Rose Sheet
Executive Summary
FDA invites public comments on the constitutionality of its approach to regulating advertising and marketing practices for cosmetics, drugs and other products in a notice appearing in the May 16 Federal Register